Life-extension drugs
Phone : + 44 703-183-8510
Life-extension drugs

Red Wine high in Resveratrol scientific update

 

Biomed Pharmacother. 2008 Jul 9.
Palsamy P, Subramanian S.
Department of Biochemistry, University of Madras, Guindy Campus, Chennai 600 025, Tamilnadu, India.

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats.

Resveratrol is a polyphenolic phytoalexin produced in appreciable amounts as a secondary metabolite in grapevines in response to fungal infections. Based on the present knowledge, it appears to be a promising bioactive natural molecule with potential applications in phytotherapy or pharmacology. The present study was aimed to evaluate the antidiabetic properties of resveratrol in streptozotocin-nicotinamide induced experimental diabetes in rats. The diabetic rats orally treated with resveratrol (5mgkg(-)(1)b.wd(-)(1)) for 30days resulted in significant (p<0.05) decrease in the levels of blood glucose, glycosylated hemoglobin, blood urea, serum uric acid, serum creatinine and diminished activities of pathophysiological enzymes such as aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP). The antihyperglycemic nature of resveratrol is also evidenced from the improvement in the levels of plasma insulin and hemoglobin. Further, the results are comparable with glyclazide, an oral standard drug. Thus, the present findings suggest that resveratrol may be considered as an effective therapeutic agent for the treatment of diabetes mellitus.


CNS Neurosci Ther. 2008 Jul 29.
Rocha-González HI, Ambriz-Tututi M, Granados-Soto V.
Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados, Sede Sur, México, D.F., Mexico.

Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases.

Resveratrol is a phytoalexin structurally related to stilbenes, which is synthesized in considerable amounts in the skin of grapes, raspberries, mulberries, pistachios and peanuts, and by at least 72 medicinal and edible plant species in response to stress conditions. It was isolated in 1940 and did not maintain much interest for around five decades until its role in treatment of cardiovascular diseases was suggested. To date, resveratrol has been identified as an agent that may be useful to treat cancer, pain, inflammation, tissue injury, and other diseases. However, currently the attention is being focused in analyzing its properties against neurodegenerative diseases and as antiaging compound. It has been reported that resveratrol shows effects in in vitro models of epilepsy, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and nerve injury. However, evidences in vivo as well as in human beings are still lacking. Thus, further investigations on the pharmacological effects of resveratrol in vivo are necessary before any conclusions on its effects on neurodegenerative diseases can be obtained.


Hum Exp Toxicol. 2008 Apr;27(4):347-53.
Eybl V, Kotyzová D, Cerná P, Koutensky J.
Department of Pharmacology and Toxicology, Charles University in Prague, Faculty of Medicine in Pilsen, Karlovarská 48, 301 66 Pilsen, Czech Republic.

Effect of melatonin, curcumin, quercetin, and resveratrol on acute ferric nitrilotriacetate (Fe-NTA)-induced renal oxidative damage in rats.

The influence of melatonin, curcumin, quercetin, and resveratrol pretreatment on ferric nitrilotriacetate (Fe-NTA)-induced oxidative renal damage was studied. Male Wistar rats were treated orally once daily for 3 days with melatonin (10 mg/kg), curcumin (50 mg/kg), quercetin (15 mg/kg), and resveratrol (10 mg/kg). One hour after the last dose of antioxidants, a single dose of Fe-NTA was administered (8 mg of Fe/kg body weight, i.p.) to pre-treated animals. Twenty-four hours after Fe-NTA administration, the lipid peroxidation (LP), reduced glutathione (GSH), catalase (CAT), and glutathione peroxidase (GSH-Px) were estimated in kidney homogenates. Iron, zinc, and copper concentrations were estimated in kidney tissue. Administration of Fe-NTA to rats induced renal LP (170%, P < 0.001) and inhibited catalase (78%, P < 0.05) in the kidney. The oral pretreatment with melatonin, curcumin, quercetin, and resveratrol each one was effective in decreasing the Fe-NTA-induced LP (P < 0.001); however, it did not influence the FeNTA-induced inhibition of renal CAT activity. No changes were found in renal GSH level and GSH-Px activity compared to control animals. The pretreatment with antioxidants did not affect the increase in renal iron content, blood urea nitrogen/creatinine ratio, and relative kidney weight of FeNTA-intoxicated rats. The results indicate that the pretreatment with natural antioxidants, curcumin, melatonin, quercetin, and resveratrol, significantly and equally suppressed lipid peroxidation induced by Fe-NTA but had no effect on other markers of FeNTA nephrotoxicity and iron deposition in kidneys.


Clin Interv Aging. 2008;3(2):331-9.
Markus MA, Morris BJ.
chool of Medical Sciences, Bosch Institute, The University of Sydney, Sydney, NSW, Australia.

Resveratrol in prevention and treatment of common clinical conditions of aging.

Resveratrol is a potent member of the class of natural, plant-derived chemicals known as polyphenols. These help explain in part why a diet high in fruit and vegetables confers health benefits and are associated with reduced risk of common complex conditions such as cardiovascular disease, cancer, diabetes, and Alzheimer's disease. We present the latest molecular findings that account for the beneficial actions of resveratrol. The intracellular pathways activated are crucial for anti-oxidant defence, regulation of the cell cycle, mitochondrial energy production, vascular tone, oncogene suppression, and many other phenomena which if unchecked lead to morbidity and mortality from onset and progression of these various diseases. While a healthy diet and lifestyle is strongly recommended in prevention of such conditions, the future bodes well for the use of resveratrol and analogues of higher potency than the natural form for treatment of diseases that afflict humans, particularly as they age.


Chin Med J (Engl). 2008 Jul 5;121(13):1204-9.
Jiang YG, Peng T, Luo Y, Li MC, Lin YH.
Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Resveratrol reestablishes spermatogenesis after testicular injury in rats caused by 2, 5-hexanedione.

BACKGROUND: Environmental toxins can destroy the physiological process of spermatogenesis and even lead to male infertility. Resveratrol (RES) is a natural phytoalexin with a wide range of biological activities. Some recent researches have demonstrated that RES can increase sperm output and protect sperm from apoptosis caused by physical damage. However, there is no evidence indicating that it can also exhibit a similar activity in testis injury caused by environmental toxins. This study was designed to evaluate the protective effect of resveratrol on testis damaged by environmental toxins and to elucidate the possible mechanism of its protective effect. METHODS: In this study 2, 5-hexanedione (2, 5-HD) was used as the injury agent. Forty male SD rats were randomly divided into 5 groups. During the first 5 weeks, group A was raised normally, groups B, C, D and E were exposed to 1% 2, 5-HD; during the following 9 weeks, group C, D, E received intragastric administration of different concentrations of resveratrol (20 mg x kg(-1) x d(-1), 40 mg x kg(-1) x d(-1) and 80 mg x kg(-1) x d(-1)), while groups A and B were treated by carboxymethylcellulose. Physical signs, body weight gain and testis weight were comparatively observed. Numbers and diameters of seminiferous tubules were analyzed following HE staining. In addition, expression of the c-kit protein and gene in spermatogenic cells in every group was detected with immunohistochemistry, Western blot or RT-PCR. RESULTS: The 2, 5-HD treatment resulted in physical signs that became worse and in emarciated testis. HE staining and immunohistochemistry showed that seminiferous tubules became emarcid, obsolete spermatogonia being stagnant and expression of c-kit protein being depressed. After oral administration of resveratrol, the 2, 5-HD-induced physical signs were improved and close to the normal rats. The gain of body weight increased (P < 0.01). The recovery of testis weight was significant (P < 0.01). At the histological level, the seminiferous epithelia began to differentiate (P < 0.01); and even the physiological process of spermatogenesis restarted. Moreover, expression of c-kit protein and gene function resumed, although its expression remained different from the normal group. The diameter of and number of seminiferous tubules and the expression level of c-kit protein and gene activity were much closer to the normal group with increased doses of the resveratrol through oral administration. CONCLUSIONS: Resveratrol could ameliorate markedly the dyszoospermia induced by 2, 5-HD and induce spermatogenesis. The expression of c-kit, which is a specific marker protein of spermatogenic cell membranes, could be regulated by resveratrol.


J Nutr. 2008 Sep;138(9):1602-8.
Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, Ghiselli A, Momi S, Violi F.
Department of Internal Medicine, Division of Internal and Cardiovascular Medicine, University of Perugia, 06100 Perugia, Italy.

Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production.

The mechanisms through which moderate wine consumption reduces ischemic cardiovascular events are not yet fully unraveled. Grape extracts or a mixture of the polyphenols contained in wine were previously shown to increase nitric oxide (NO); however, little information is available on the effect of resveratrol, one of the main polyphenols of wine, on platelet NO production. We assessed the effects of resveratrol, at the concentrations attainable after moderate wine intake, on platelet NO production and the mechanism of this activity. Twenty healthy volunteers were studied before and after 15 d of controlled white or red wine intake (300 mL/d). After wine intake, plasma resveratrol and the release of NO by stimulated platelets increased significantly. Resveratrol, at the concentrations detected in plasma after wine intake, was incubated in vitro with washed platelets and several variables related to NO production and to signal transduction were measured. Resveratrol in vitro enhanced significantly the production of NO by stimulated platelets, the activity of platelet NO synthase (NOS), phosphorylation of protein kinase B, an activator of the endothelial NOS (eNOS), and phosphorylation of vasodilator-activated protein (VASP), an expression of the biologic activity of NO in platelets. Simultaneously, we observed decreased phosphorylation of P38 mitogen-activated protein kinase (p38MAPK), a proinflammatory pathway in human platelets, a reduction of the activity of NADPH oxidase, a major source of reactive oxygen species (ROS) and of the generation of O(2)(-) radicals, as detected by cytochrome C reduction. In conclusion, resveratrol, at concentrations attainable after moderate wine intake, activates platelet eNOS and in this way blunts the proinflammatory pathway linked to p38MAPK, thus inhibiting ROS production and ultimately platelet function. This activity may contribute to the beneficial effects of moderate wine intake on ischemic cardiovascular disease.


Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):772-6.
Li T, Wang W, Li T.
Department of Immunology, Medical College of the Chinese Armed Police Force, Tianjin 300162, China.

[Regulatory Effect of Resveratrol on JAK1/STAT3 Signal Transduction Pathway in Leukemia.] [Article in Chinese]

The aim of this study was to explore the molecule mechanism of resveratrol antileukaemia. The mouse lymphocytic leukemia L1210 cells were cultured and the expressions of pJAK1 and pSTAT3 protein in L1210 cells were detected by immunohistochemistry and immunoprecipitation in vitro. The mouse model with L1210 leukemia ascites carcinoma was established and activities of singal transduction pathway molecules pJAK1 and pSTAT3 were measured by Western blot and immunohistochemistry assay in vitro. The results indicated that resveratrol could significantly inhibit the JAK1/STAT3 signal transduction pathway, down-regulate expressions of pJAK1 and pSTAT3 and reduce the phosphorylation of JAK1 and STAT3 in a dose-and time-dependent manner. It is concluded that the resveratrol can regulate signal transduction pathway and reduce the activation of JAK1/STAT3 tyrosine phosphorylation significantly, and therefore resveratrol shows chemotherapeutic potential to leukaemia.


Int J Pharm. 2008 Jul 31.
Caddeo C, Teskač K, Sinico C, Kristl J.
University of Ljubljana, Faculty of Pharmacy, Askerceva 7, 1000 Ljubljana, Slovenia; Universita di Cagliari, Facolta di Farmacia, Dipartimento Farmaco Chimico Tecnologico, Via Ospedale 72, 09124 Cagliari, Italy.

Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells.

The possibility of improving the efficacy of resveratrol, a polyphenol with strong antioxidant and free-radical scavenging properties, on cell proliferation and photoprotection by liposomal incorporation was investigated. Oligolamellar vesicles of different lipid compositions, loaded with resveratrol, were prepared and characterized by evaluating size, zeta potential, incorporation efficiency, electron microscopy and stability over 60 days. The effect of free and liposomal resveratrol on the viability of HEK 293 cells and their photoprotection after UV-B irradiation was assessed by the MTS method. Resveratrol decreased the cell viability at 100muM concentration, while at 10muM increased cell proliferation and also achieved the most effective photoprotection. Photomicrographs of the treated cells from inverted light and fluorescence microscopy demonstrated resveratrol effectiveness at 10muM, as well as its toxicity at higher concentrations, based on changes in cell shape, detachment and apoptotic features. Interestingly, liposomes prevented the cytotoxicity of resveratrol at high concentrations, even at 100muM, avoiding its immediate and massive intracellular distribution, and increased the ability of resveratrol to stimulate the proliferation of the cells and their ability to survive under stress conditions caused by UV-B light.


Red Wine high in Resveratrol description...

 

My BasketMy Basket

Drug category:
Antioxidants and Vitamines
Red Wine high in Resveratrol
Red Wine high in Resveratrol scientific update
Red Wine high in Resveratrol description
Our prices have been reduced dramatically - by 30%!!!


Product list

- ACARBOSE
- ACCUPRIL-ACCUPRO
- ACOMPLIA
- ACYCLOVIR
- ADALAT
- ADAMANTAN
- AMANTADINE
- AMARYL
- AMINOGUANIDINE
- AMITRIPTYLINE
- ARAVA
- AREDIA
- ARICEPT
- ARIMIDEX
- AUGMENTIN
- AVANDIA
- AVAPRO
- AVASTIN
- AVEMAR
- BROMOCRIPTINE
- CAMPRAL
- CAMPTO
- CASODEX
- CELEBREX
- CENTROPHENOXINE
- CIALIS
- CIPRO (CIPROBAY)
- CLOTRIMAZOLE
- COAXIL
- COENZYME Q10
- COVEREX
- COZAAR
- DEPAKOTE
- DEPO-MEDROL
- DEPRENYL
- DIFLUCAN
- DOXYCYCLINE
- E VITAMIN
- ECDYSTEN
- EFFEXOR GENERIC
- ELLAGIC ACID
- EULEXIN
- EVISTA
- FARESTON
- FAT BURNER
- FEMARA
- FISH OIL
- FLOMAX
- FOLIC ACID
- FOSAMAX
- GLEEVEC
- GLUCOBAY
- IMATINIB
- IMIGRAN
- IODIDE (KJ)
- ISOPRINOSINE
- JUMEX
- LAMISIL
- LESCOL
- LEUZEA ROOT
- LEVITRA
- LIPITOR
- LIPOIC ACID
- LOTENSIN
- MACA VIBE
- MADOPAR
- MEGACE
- METFORMIN
- METOPROLOL
- METOPROLOL RETARD
- MEVACOR
- MILGAMMA
- MIRAPEXIN
- MOBIC
- MONOPRIL
- MOVALIS
- MUMIJO (MUMIO)
- NADH
- NEURONTIN
- NEXAVAR
- NEXIUM
- NIZORAL
- NOOTROPYL
- NORVASC
- ORUNGAL
- OSELTAMIVIR
- PANTOCRIN
- PAXIL
- PIKAMILON
- PIRACETAM
- PLAVIX
- PREMARIN
- PROSCAR
- PUMPKINSEED OIL
- RED WINE EXTRACT
- RED WINE HIGH IN RESVERATROL
- REVALID
- REVALID CREAM
- REVALID HAIR TONIC
- REVALID SHAMPOO AND CONDITIONER
- RHODIOLA ROOT
- RHODIOLA TABLETS
- RIMANTADINE
- RISPERDAL
- RITUXAN
- SCHISANDRA
- SEA-BUCKTHORN OIL
- SELEGILIN
- SELENIUM
- SEROQUEL
- SINEMET
- SORAFENIB
- SPORANOX
- STABLON
- SUTENT
- TAMIFLU
- TAMOXIFEN
- TARCEVA
- TAXOL
- TEMODAR
- TOPAMAX
- TOPOTECAN
- TRITICO
- VALSTAR
- VASOTEC
- VELCADE
- VEPESID
- VIAGRA
- VINPOCETINE
- VINPOTROPILE
- WELLBUTRIN
- XALATAN
- XANTHINOL
- XELODA
- XENICAL
- ZETIA
- ZINC (ZN)
- ZITHROMAX
- ZOCOR
- ZOFRAN
- ZOLADEX
- ZOLOFT
- ZYPREXA
- ZYRTEC

eXTReMe Tracker